Prof Peter ten Dijke (LUMC), dr. Pouyan Boukany (TU Delft), Prof John Martens (Erasmus MC) and Prof Stefan Sleijfer (Erasmus MC) aim to identify and repurpose existing drugs to selectively change the behaviour of aggressive cancer cells into non-invasive and therapy sensitive cancer cells or benign fat cells.
ZonMw funding of 750,000 euros for Targeting the Mesenchymal Cancer Cell Phenotype for Therapeutic Gain
